menu

About

Our Corporate Mission

Saving lives and providing relief by tackling illnesses

BTB Drug Development Research Center endeavors to create a more harmonious society by tackling illnesses and saving lives

Message from Sawada

Our company aims to develop drugs in a manner that differs starkly from existing venture companies. We are involved in drug development projects that swiftly utilize the results of core academic research performed mainly at Kyoto University to create drugs that are of practical value in medical care.

Specifically, we utilize the results of cutting-edge core research performed in academia to create clear target product profiles (TPP), develop optimal strategies for R&D, intellectual property, and pharmaceutical regulations so as to cross the Devil's River of drug development. We then formulate optimal development plans, raise adequate funding, and provide superior project management to bridge the Valley of Death of drug development. Finally, we overcome the Darwinian Sea of drug development by developing thoughtful business strategies based on the business portfolio and focus on business development. Our company hopes to play a part in making new drugs available to patients suffering from intractable diseases as quickly as possible.

Moreover, in response to the new way of life demanded by the COVID-19 pandemic, we will take advantage of online technologies to provide development-related consultation for on-demand drug development with our team of experts, and actively cater to requests pertaining to the launch of spin-out venture companies and divestitures.

 

Brief CV of Teruo Sawada

March 1974 Completed the Master's Program at the Graduate School of Pharmaceutical Sciences, Osaka University (Pharmacist)
April 1974 Joined Kanebo, Ltd. (Clinical development)
April 1999 Merged with Nippon Organon, Ltd. (Development planning)
April 2008 Merged with Schering-Plough Corporation (Director of Medical Affairs)
July 2010 Merged with MSD, Ltd. (Manager of Medical Affairs)
March 2013 Researcher at the Department of Anatomy and Developmental Biology, Graduate School of Medicine, Kyoto University (involved in drug development research)
June 2020 Founded BTB Drug Development Research Center Co., Ltd. (Representative Director)

 

Brief CV of Masatoshi Hagiwara (Non-executive Director)

March 1988 Completed Ph.D. at the Graduate School of Medicine, Mie University (Doctor of Medicine)
April 1988 Teaching Assistant at the Department of Pharmacology, School of Medicine, Nagoya University
October 1993 Lecturer at the Department of Anatomy and Cell Biology (Group 3), School of Medicine, Nagoya University
July 1995 Assistant Professor at the Department of Anatomy and Cell Biology (Group 3), School of Medicine, Nagoya University
January 1997 Professor at the Medical Research Institute, Tokyo Medical and Dental University
April 2003 Professor at the School of Biomedical Science, Tokyo Medical and Dental University
July 2010 Professor at the Department of Anatomy and Developmental Biology, Graduate School of Medicine, Kyoto University (current appointment)
November 2011 Founded the Medical Research Support Center at Kyoto University, and serving as its Director (current appointment)

 

Brief CV of Tetsuji Nagamoto (Non-executive Director & Head of Licensing Operations)

Graduated from the School of Medicine, Kyoto University (Medical doctor)
April 2005 Research Assistant at the Trade Policy Unit, Economic & Social Policy Department, Policy Research Division, UFJ Research Institute
April 2008 Consultant at the Life Sciences Unit, Deloitte Tohmatsu Consulting, LLC.
April 2012 Resident & Advisor to the Clinical Trials Steering Committee at the Nanbu Medical Center / Nanbu Child Medical Center
April 2014 Pediatrician at the Yokosuka General Hospital Uwamachi
May 2016 Senior Principal at the Health & Public Services Division, Accenture
June 2017 CHARTAE Consulting, LLC. (Founded~present: concurrent appointment)
Other concurrent appointments Researcher at the Department of Systems Science, Graduate School of Informatics, Kyoto University
Researcher at the Department of Materials Process Engineering, Graduate School of Engineering, Nagoya University
Part-time Lecturer at the Faculty of Advanced Techno-Surgery, Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University
Part-time Faculty Member at the Division of Intelligent Systems Engineering, Graduate School of Engineering, Yokohama National University

 

Brief CV of Tsuyoshi Ogiku (Development Advisor)

March 1983 Completed the Master's Program at the Graduate School of Science, Osaka University
April 1983 Joined Tanabe Pharma Corporation (currently Mitsubishi Tanabe Pharma Corporation) as a medicinal chemist
December 1992 Graduated from the Graduate School of Science, Osaka University (Doctor of Science)
April 2010 General Manager of Medicinal Chemistry Laboratories(1)
April 2013 General Manager of the Exploratory Screening Center
July 2015 General Manager of Research Core Units
October 2015 Deputy Director of R & D Division
September 2016 Specially-appointed Professor at the Graduate School of Medicine, Kyoto University (current appointment)
April 2017 Senior URA/Deputy Director of the Research Administration Office, Kyoto University (current appointment)
April 2018 Director of Clinical Development at the Clinical Research Center (currently Institute for Advancement of Clinical and Translational Science), Kyoto University Hospital (current appointment)

 

Brief CV of Nobuya Matsuoka (Development Advisor)

March 1983 Graduated from the Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kyoto University (Pharmacist)
April 1983 Joined Fujisawa Pharmaceutical Co., Ltd. as a researcher at the Exploratory Research Laboratory
May 1991 Head of Basic Research Group, Fujisawa Pharmaceutical Co., Ltd.
January 1993 Obtained Ph.D. of Pharmaceutical Sciences from Kyoto University
April 1994 Visiting Scientist at the National Institute of Mental Health (NIMH), National Institutes of Health (NIH)
May 1995 Chief Scientist at the Exploratory Research Laboratory, Fujisawa Pharmaceutical Co., Ltd.
October 1998 Group Leader of the CNS Diseases Group, Pharmacology Research Laboratory, Fujisawa Pharmaceutical Co., Ltd.
October 1999 Head of the CNS Diseases Laboratory, Pharmacology Research Laboratory, Fujisawa Pharmaceutical Co., Ltd.
October 2003 Director of CNS Research, Fujisawa Pharmaceutical Co., Ltd.
April 2005 Merged into Astellas Pharma Inc., and appointed as the Director of the Neuroscience Laboratory, Pharmacology Research Laboratory
October 2011 General Manager of the Strategic Research Alliance, Research Promotion Division, Astellas Pharma Inc.
April 2013 General Manager of the R&D Department, Central Research Laboratory, Kobayashi Pharmaceutical Co., Ltd.
April 2016 Corporate Officer of Kobayashi Pharmaceutical Co., Ltd. and Director of the Central Research Laboratory
January 2019 Senior Research Administrator at the Research Administration Office, Kyoto University (current appointment)

 

Company Profile

Company name BTB Drug Development Research Center Co.,Ltd.
Representative Teruo Sawada (Representative Director)
Founded June 29th, 2020
Capital 7 million yen
Headquarters 〒606-8404
Jodoji-Shimominamidacho 90-4, Sakyo-ku, Kyoto
E-mail: info@btb-newdrug.co.jp
Page Top